Filing Details
- Accession Number:
- 0001209191-18-062513
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-13 18:24:15
- Reporting Period:
- 2018-12-11
- Accepted Time:
- 2018-12-13 18:24:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337798 | Bradley G Cole | 301 Penobscot Drive Redwood City CA 94063 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-12-06 | 1,633 | $0.00 | 44,047 | No | 5 | G | Indirect | Held by the Cole Family Trust |
| Common Stock | Acquisiton | 2018-12-11 | 10,000 | $22.98 | 54,047 | No | 4 | M | Indirect | Held by the Cole Family Trust |
| Common Stock | Acquisiton | 2018-12-11 | 5,000 | $17.18 | 59,047 | No | 4 | M | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 2,529 | $70.58 | 56,518 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 4,571 | $71.54 | 51,947 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 700 | $72.73 | 51,247 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 900 | $73.56 | 50,347 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 1,300 | $74.61 | 49,047 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 1,400 | $70.61 | 47,647 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 2,200 | $71.53 | 45,447 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 600 | $73.10 | 44,847 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Common Stock | Disposition | 2018-12-11 | 800 | $74.42 | 44,047 | No | 4 | S | Indirect | Held by the Cole Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Indirect | Held by the Cole Family Trust |
| No | 4 | M | Indirect | Held by the Cole Family Trust |
| No | 4 | M | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
| No | 4 | S | Indirect | Held by the Cole Family Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-12-11 | 5,000 | $0.00 | 5,000 | $17.18 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-12-11 | 10,000 | $0.00 | 10,000 | $22.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 36,471 | 2020-02-18 | No | 4 | M | Direct | |
| 46,424 | 2021-01-27 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 16,534 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 23, 2018.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $70.08 to $71.07.
- Represents weighted average sale price. Actual sale prices ranged from $71.11 to $72.05.
- Represents weighted average sale price. Actual sale prices ranged from $72.11 to $72.97.
- Represents weighted average sale price. Actual sale prices ranged from $73.14 to $74.00.
- Represents weighted average sale price. Actual sale prices ranged from $74.29 to $75.22.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018.
- Represents weighted average sale price. Actual sale prices ranged from $70.07 to $71.05.
- Represents weighted average sale price. Actual sale prices ranged from $71.11 to $72.05.
- Represents weighted average sale price. Actual sale prices ranged from $72.65 to $73.45.
- Represents weighted average sale price. Actual sale prices ranged from $73.96 to $74.91.
- The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter.
- The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter.
Billionaire Hedge Funds
